Chimeric Antigen Receptor T-Cell (CAR-T) & Gene Rx

Cellular & Gene Therapy Program @ KFSHRC KSA #CART #bmtsm #immunotherapy #tcellrx #ICAN #CRS #CARTcells #CellTherapy #Gene #Genetherapy @ASTCT @CART_Therapy

[Chimeric Antigen Receptor T-Cell (CAR-T) & Gene Rx @CARTTherapy]

Final results of nilotinib versus nilotinib combined with pegylated interferon alfa-2a as first-line therapy in chronic phase chronic myeloid leukaemia in France (PETALs): an open-label, multicentre, randomised phase 3 trial - The Lancet Haematology https://t.co/SW2lSR3LgB

[Chimeric Antigen Receptor T-Cell (CAR-T) & Gene Rx @CARTTherapy]

Randomized, Placebo-Controlled Trial of B-Cell Depletion for Prevention of Corticosteroid-Requiring Chronic Graft-Versus-Host Disease | Journal of Clinical Oncology https://t.co/Cpt6OCNkbJ

[Chimeric Antigen Receptor T-Cell (CAR-T) & Gene Rx @CARTTherapy]

From Molecular Complexity to Personalized Care in Chronic Myelomonocytic Leukemia | Journal of Clinical Oncology https://t.co/Iskt80EqwK

[Chimeric Antigen Receptor T-Cell (CAR-T) & Gene Rx @CARTTherapy]

Circulating Tumor DNA Assessment of Disease Response in Large B-Cell Lymphoma: Lisocabtagene Maraleucel Versus Autologous Stem Cell Transplantation Standard Therapy | Journal of Clinical Oncology https://t.co/D2ViKjBoxb

[Chimeric Antigen Receptor T-Cell (CAR-T) & Gene Rx @CARTTherapy]

Trends in survival outcomes after allogeneic transplantation for MDS and MDS/MPN in a real-world experience: A 25-year nationwide study
https://t.co/KqKLc0LQiR

[Chimeric Antigen Receptor T-Cell (CAR-T) & Gene Rx @CARTTherapy]

Treosulfan–fludarabine conditioning in infants with severe combined immunodeficiencies: Extended study of the UK paediatric treosulfan study
https://t.co/DrcU3qVL4p

[Mostafa Faisal @MostafaFaisal14]

Asciminib in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Case Series and Review of Emerging Evidence | MDPI https://t.co/llz0wAYWkF

[Chimeric Antigen Receptor T-Cell (CAR-T) & Gene Rx @CARTTherapy]

Concomitant or sequential lower intensity triplet therapy in AML - The Lancet Haematology https://t.co/bX0WXhWCU9

[Chimeric Antigen Receptor T-Cell (CAR-T) & Gene Rx @CARTTherapy]

Oral deucrictibant for prophylaxis of hereditary angioedema attacks (CHAPTER-1): primary analysis of a randomised, double-blind, placebo-controlled, phase 2 trial - The Lancet Haematology https://t.co/4sETCXfgVB

[Chimeric Antigen Receptor T-Cell (CAR-T) & Gene Rx @CARTTherapy]

Who will watch the watchmen: unique challenges of T-cell redirecting therapies in T-cell malignancies - The Lancet Haematology https://t.co/P9TbI75GQc

[Chimeric Antigen Receptor T-Cell (CAR-T) & Gene Rx @CARTTherapy]

Randomized trial of GvHD Prophylaxis in Haploidentical PBSC Transplantation: ATG, PTCy, and Low-Dose Combination Therapy https://t.co/bwZgnEUcqV

[Chimeric Antigen Receptor T-Cell (CAR-T) & Gene Rx @CARTTherapy]

Ferric Carboxymaltose Increases Fracture Risk in Patients and Reduces Bone Formation in Mice with Iron Deficiency Anemia https://t.co/iotwKZAjMY

[Chimeric Antigen Receptor T-Cell (CAR-T) & Gene Rx @CARTTherapy]

Discovery and preclinical activity of the menin-KMT2A inhibitor ziftomenib in acute leukemia models https://t.co/EFMatJ6gX0

[Chimeric Antigen Receptor T-Cell (CAR-T) & Gene Rx @CARTTherapy]

Tocilizumab as stabilizing frontline treatment in suspected KSHV inflammatory cytokine syndrome https://t.co/yrvQyPE4zr

[Chimeric Antigen Receptor T-Cell (CAR-T) & Gene Rx @CARTTherapy]

Early Steroid and Anakinra Use to Manage Axicabtagene Ciloleucel Toxicity Reduces the Total Duration of CRS and ICANS https://t.co/KQPkLsGt25

[Chimeric Antigen Receptor T-Cell (CAR-T) & Gene Rx @CARTTherapy]

Pulmonary Complications Following Hematopoietic Cell Transplantation in Patients with Myelofibrosis: https://t.co/qpef2Q1c7D

[Chimeric Antigen Receptor T-Cell (CAR-T) & Gene Rx @CARTTherapy]

Blinatumomab in Combined Immune Thrombocytopenia and Antiphospholipid Syndrome | New England Journal of Medicine https://t.co/n2vsCBv3H1

[Chimeric Antigen Receptor T-Cell (CAR-T) & Gene Rx @CARTTherapy]

Varnimcabtagene autoleucel for adults with relapsed or refractory B-cell precursor acute lymphoblastic leukaemia in Spain (CART19-BE-02): a multicentre, single-arm, phase 2 trial - The Lancet Haematology https://t.co/BbHrjvsyu2

[Chimeric Antigen Receptor T-Cell (CAR-T) & Gene Rx @CARTTherapy]

Romiplostim versus Placebo for Chemotherapy-Induced Thrombocytopenia | New England Journal of Medicine https://t.co/QInnOJ6jgn

[Chimeric Antigen Receptor T-Cell (CAR-T) & Gene Rx @CARTTherapy]

DB-OTO Gene Therapy for Inherited Deafness | New England Journal of Medicine https://t.co/Yba5pmfQgU